BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15341919)

  • 1. Loss of SHP-1 phosphatase alters cytokine expression in the mouse hindbrain following cochlear ablation.
    Zhao J; Lurie DI
    Cytokine; 2004 Oct; 28(1):1-9. PubMed ID: 15341919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-alpha, and IL-1beta.
    Zhao J; Brooks DM; Lurie DI
    Glia; 2006 Feb; 53(3):304-12. PubMed ID: 16265671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear ablation in mice lacking SHP-1 results in an extended period of cell death of anteroventral cochlear nucleus neurons.
    Zhao J; Lurie DI
    Hear Res; 2004 Mar; 189(1-2):63-75. PubMed ID: 14987753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
    Beamer CA; Brooks DM; Lurie DI
    J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia.
    Bonaparte KL; Hudson CA; Wu C; Massa PT
    Glia; 2006 Jun; 53(8):827-35. PubMed ID: 16565987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
    White ED; Andrews RP; Hershey GK
    J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.
    Khaled AR; Butfiloski EJ; Sobel ES; Schiffenbauer J
    Cell Immunol; 1998 Apr; 185(1):49-58. PubMed ID: 9636682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes.
    Massa PT; Saha S; Wu C; Jarosinski KW
    Glia; 2000 Feb; 29(4):376-85. PubMed ID: 10652447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
    Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
    Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
    Lyons BL; Smith RS; Hurd RE; Hawes NL; Burzenski LM; Nusinowitz S; Hasham MG; Chang B; Shultz LD
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1201-9. PubMed ID: 16505059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
    Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
    J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
    Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
    J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1.
    Forget G; Matte C; Siminovitch KA; Rivest S; Pouliot P; Olivier M
    Eur J Immunol; 2005 Jun; 35(6):1906-17. PubMed ID: 15902687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain.
    Wishcamper CA; Coffin JD; Lurie DI
    J Comp Neurol; 2001 Dec; 441(2):118-33. PubMed ID: 11745639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
    Joliat MJ; Lang PA; Lyons BL; Burzenski L; Lynes MA; Yi T; Sundberg JP; Shultz LD
    J Autoimmun; 2002 Mar; 18(2):105-17. PubMed ID: 11908943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHP-1 expression in avian mixed neural/glial cultures.
    Sorbel JD; Brooks DM; Lurie DI
    J Neurosci Res; 2002 Jun; 68(6):703-15. PubMed ID: 12111831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
    An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
    Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphatase SHP-1 immunoreactivity increases in a subset of astrocytes following deafferentation of the chicken auditory brainstem.
    Lurie DI; Solca F; Fischer EH; Rubel EW
    J Comp Neurol; 2000 May; 421(2):199-214. PubMed ID: 10813782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.